Innospark Ventures logo

Innospark Ventures

North America, Massachusetts, United States, Boston

Description

Innospark Ventures is an early-stage venture capital firm based in Boston, Massachusetts, dedicated to investing in impact-driven artificial intelligence (AI) startups. The firm primarily targets pre-seed and seed-stage companies within the Boston and broader New England ecosystem. Their investment thesis centers on "AI for Good," seeking out innovative applications of AI that address critical societal challenges across sectors such as healthcare, education, climate change, and social impact. This specialized focus allows Innospark to provide targeted support and expertise to founders leveraging AI for positive real-world outcomes.

Innospark Ventures typically provides initial cheques ranging from $250,000 to $1,000,000, positioning them as a key early-stage capital provider. They often take a leading or co-leading role in funding rounds, with a preference for total round sizes between $1,000,000 and $3,000,000. This strategic approach enables them to be significant partners in the foundational stages of their portfolio companies' growth. The firm successfully closed its inaugural fund, Innospark Ventures Fund I, at $50 million, demonstrating substantial capital dedicated to their impact-driven AI mandate.

Beyond capital, Innospark Ventures emphasizes a hands-on approach, leveraging the deep operational and entrepreneurial experience of its partners, including founder Dr. Venkat Srinivasan. Their commitment extends to providing strategic guidance, mentorship, and access to a robust network, aiming to accelerate the development and market penetration of their portfolio companies. With a portfolio that includes over 15 investments as of early 2024, Innospark Ventures has established itself as a prominent and specialized investor within the burgeoning AI startup landscape of New England, actively shaping the future of AI for social good.

Investor Profile

Innospark Ventures has backed more than 53 startups, with 5 new investments in the last 12 months alone. The firm has led 17 rounds, about 32% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States, Canada, India.
  • Strong thematic focus on Artificial Intelligence (AI), Software, Information Technology.
  • Led 1 rounds in the past year.
  • Typical check size: $250K – $1M.

Stage Focus

  • Seed (53%)
  • Series A (19%)
  • Pre Seed (11%)
  • Series Unknown (8%)
  • Series B (8%)
  • Corporate Round (2%)

Country Focus

  • United States (66%)
  • Canada (15%)
  • India (13%)
  • United Kingdom (4%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Software
  • Information Technology
  • Health Care
  • Machine Learning
  • Biotechnology
  • Saas
  • Medical
  • Education
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Innospark Ventures frequently co-invest with?

Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
BDC Capital’s Women in Technology Venture Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
PJC
North America, Massachusetts, United States, Boston
Co-Investments: 2
Nor'easter Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Insight Partners
North America, New York, United States, New York
Co-Investments: 2
Y Combinator
North America, California, United States, Mountain View
Co-Investments: 4
Flint Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
MetaProp
North America, New York, United States, New York
Co-Investments: 3
1Crowd
Asia, Maharashtra, India, Mumbai
Co-Investments: 4
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 3

Which angels does Innospark Ventures often collaborate with?

Shared Deals: 1
CT
North America, Massachusetts, United States, Boston
Shared Deals: 1
AF
North America, California, United States, San Francisco
Shared Deals: 1
Nick Romano
North America, Ontario, Canada, Toronto
Shared Deals: 1
JJ
North America, California, United States, Menlo Park
Shared Deals: 1
PS
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
AR
North America, California, United States
Shared Deals: 1
AA
North America, California, United States, San Francisco
Shared Deals: 1
AS
North America, California, United States, Menlo Park
Shared Deals: 1
PG
North America, California, United States, Mountain View
Shared Deals: 1

What are some of recent deals done by Innospark Ventures?

Juniper Genomics

Toronto, Ontario, Canada

Juniper Genomics brings modern genomics and data science to help overcome barriers and challenges facing IVF patients.

SeedJun 26, 2025
Amount Raised: $4,600,000
ArrePath

Princeton, New Jersey, United States

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

BiotechnologyHealth CareMedical
SeedJun 23, 2025
Copernic Catalysts

Cambridge, Massachusetts, United States

Copernic Catalysts develops sustainable chemical catalysts and processes.

ChemicalChemical EngineeringOil and Gas
SeedNov 12, 2024
Amount Raised: $8,000,000
Phaseshift Technologies

Toronto, Ontario, Canada

Accelerating the development and deployment of next-generation engineering materials through AI and Computational Materials Engineering.

Advanced MaterialsArtificial Intelligence (AI)Information TechnologyMachine LearningQuantum Computing
SeedOct 21, 2024
Amount Raised: $2,963,704
Antiverse

Cardiff, Cardiff, United Kingdom

Antiverse is dedicated to engineering the future of drug development to change the course of people's lives.

Artificial Intelligence (AI)BiotechnologyHealth CareLife ScienceMachine Learning
SeedOct 15, 2024
Amount Raised: $4,572,707
Haloo

Toronto, Ontario, Canada

Heirlume aims to make the complex process of trademarking faster, more accurate, and more affordable.

B2BBlockchainCryptocurrencyEnterprise SoftwareSaaSWeb3
Series AJun 28, 2024
Amount Raised: $3,432,035
Marigold Health

Boston, Massachusetts, United States

Marigold Health uses chat support groups to make substance use treatment more engaging and personalized for vulnerable populations.

Artificial Intelligence (AI)Health CareHealth DiagnosticsMedicalNatural Language ProcessingPsychology
Series AJun 18, 2024
Amount Raised: $11,000,000
BioIntelligence Technologies

Sherbrooke, Quebec, Canada

BioIntelligence Technologies offers real-time automated analytics tools.

AnalyticsDatabaseInformation Technology
SeedApr 23, 2024
Amount Raised: $3,659,813
Via Scientific

Cambridge, Massachusetts, United States

Via Scientific to help scientists and bioinformaticians generate novel science that improves the world.

BiotechnologyMedical
SeedJan 9, 2024
Amount Raised: $5,000,000
Karma Healthcare

Udaipur City, Rajasthan, India

Technology enabled equitable healthcare for India.

Health CareHospitalMedical Device
Series AJun 26, 2023